Endocan, a potential prognostic and diagnostic biomarker of acute leukemia
- 17 June 2014
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 395 (1-2) , 117-123
Abstract
Recent evidence indicated that endocan may be a potential cell marker and a new target for cancers including acute leukemia since the serum endocan level in patients with acute leukemia was associated with the status of the disease, i.e., endocan was higly expressed in untreated acute leukemia, but decreased after chemotherapy and increased again during bone marrow regeneration. The present study showed that there was high level expression of endocan in cytoplasm of bone marrow blasts of patients with acute myeloid leukemia or acute lymphoblastic leukemia. The expression level of endocan was significantly decreased when the patients underwent remission after chemotherapy and re-bounces back when the acute leukemia relapsed. No obvious change in expression of endocan was observed before and after chemotherapy if the patients showed no remission after chemotherapy. (N-(4-Hydroxyphenyl) retinamide), a potent anti-angiogenic agent, could not only down-regulate the expression of vascular epithelial growth factor, but also decrease endocan transcription and expression in NB4 cells, a human acute promyelocytic leukemia cell line. These observations suggest that endocan could act as a predictor for the severity and the prognosis of acute leukemia. The findings could be used as the basis for future targeted therapy directed against bone marrow angiogenesis in acute leukemia treatment.Keywords
This publication has 21 references indexed in Scilit:
- Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathwayCarcinogenesis, 2012
- Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemiaHematology, 2011
- Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulationEuropean Journal of Haematology, 2010
- Contribution of bone microenvironment to leukemogenesis and leukemia progressionLeukemia, 2009
- Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implicationsFrontiers in Bioscience-Landmark, 2009
- Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediatorsBritish Journal of Haematology, 2008
- Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancerExperimental Cell Research, 2007
- Ceramide synthesis and metabolism as a target for cancer therapyCancer Letters, 2004
- Role of the microenvironment in promoting angiogenesis in acute myeloid leukemiaAmerican Journal of Hematology, 2002
- Identification of Endothelial Cell Genes Expressed in an in Vitro Model of Angiogenesis: Induction of ESM-1, βig-h3, and NrCAMMicrovascular Research, 2002